Business Context and Reporting Period
This Form 8-K, filed on January 30, 2020, reports on a Special Meeting of Stockholders held by Crescent Capital BDC, Inc. on January 29, 2020. The filing details the unanimous approval of proposals related to the Company's reincorporation from Delaware to Maryland and a merger transaction with Alcentra Capital Corporation.
Key Financial Metrics
This filing is a current report regarding corporate governance and transactional events. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes and Transaction Details
- Reincorporation: Stockholders approved the merger to reincorporate the Company from Delaware to Maryland.
- Merger with Alcentra: Stockholders approved the issuance of common stock to effectuate the merger with Alcentra Capital Corporation.
- Investment Advisory Agreement: Stockholders approved the Amended and Restated Investment Advisory Agreement with Crescent Cap Advisors, LLC.
- Voting Results: All four proposals were approved with 18,662,457.146 votes FOR, 0 AGAINST, and 0 ABSTAIN out of 20,862,314 shares entitled to vote.
Guidance, Outlook, and Management Commentary
Management expects to close the transactions contemplated by the Merger Agreement on January 31, 2020, subject to customary closing conditions. Following the closing, the Company's common stock is expected to begin publicly trading on the NASDAQ Global Market under the symbol CCAP on February 3, 2020. No specific financial guidance or risk factors regarding future performance were detailed in this specific filing text.
Important Facts for Investor Verification
- Verify the closing of the merger transaction on or around January 31, 2020.
- Confirm the commencement of trading under the new ticker symbol CCAP on February 3, 2020.
- Review the terms of the Amended and Restated Investment Advisory Agreement approved by stockholders.
- Monitor subsequent filings for the updated capital structure and financial impact of the Alcentra merger.